![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: NCOA7 |
Gene summary for NCOA7 |
![]() |
Gene information | Species | Human | Gene symbol | NCOA7 | Gene ID | 135112 |
Gene name | nuclear receptor coactivator 7 | |
Gene Alias | ERAP140 | |
Cytomap | 6q22.31-q22.32 | |
Gene Type | protein-coding | GO ID | GO:0006139 | UniProtAcc | B3KXK4 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
135112 | NCOA7 | CA_HPV_1 | Human | Cervix | CC | 2.55e-03 | -4.44e-02 | 0.0264 |
135112 | NCOA7 | CCI_2 | Human | Cervix | CC | 2.40e-03 | 8.17e-01 | 0.5249 |
135112 | NCOA7 | sample1 | Human | Cervix | CC | 9.35e-14 | 7.63e-01 | 0.0959 |
135112 | NCOA7 | L1 | Human | Cervix | CC | 1.10e-02 | -3.17e-01 | 0.0802 |
135112 | NCOA7 | T1 | Human | Cervix | CC | 2.70e-23 | 7.46e-01 | 0.0918 |
135112 | NCOA7 | LZE4T | Human | Esophagus | ESCC | 6.42e-05 | 1.06e+00 | 0.0811 |
135112 | NCOA7 | LZE8T | Human | Esophagus | ESCC | 2.33e-14 | 1.38e+00 | 0.067 |
135112 | NCOA7 | LZE24T | Human | Esophagus | ESCC | 6.48e-20 | 2.20e+00 | 0.0596 |
135112 | NCOA7 | LZE21T | Human | Esophagus | ESCC | 1.78e-03 | 1.12e+00 | 0.0655 |
135112 | NCOA7 | P1T-E | Human | Esophagus | ESCC | 3.45e-09 | 1.52e+00 | 0.0875 |
135112 | NCOA7 | P2T-E | Human | Esophagus | ESCC | 2.33e-62 | 2.61e+00 | 0.1177 |
135112 | NCOA7 | P4T-E | Human | Esophagus | ESCC | 1.83e-27 | 2.40e+00 | 0.1323 |
135112 | NCOA7 | P5T-E | Human | Esophagus | ESCC | 1.20e-03 | 6.93e-01 | 0.1327 |
135112 | NCOA7 | P8T-E | Human | Esophagus | ESCC | 1.05e-27 | 2.17e+00 | 0.0889 |
135112 | NCOA7 | P9T-E | Human | Esophagus | ESCC | 8.61e-06 | 3.83e-01 | 0.1131 |
135112 | NCOA7 | P11T-E | Human | Esophagus | ESCC | 3.40e-03 | 8.06e-01 | 0.1426 |
135112 | NCOA7 | P15T-E | Human | Esophagus | ESCC | 1.42e-20 | 1.81e+00 | 0.1149 |
135112 | NCOA7 | P16T-E | Human | Esophagus | ESCC | 3.46e-25 | 1.36e+00 | 0.1153 |
135112 | NCOA7 | P20T-E | Human | Esophagus | ESCC | 5.44e-29 | 2.37e+00 | 0.1124 |
135112 | NCOA7 | P21T-E | Human | Esophagus | ESCC | 1.15e-40 | 2.50e+00 | 0.1617 |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:000697910 | Cervix | CC | response to oxidative stress | 102/2311 | 446/18723 | 2.99e-10 | 4.36e-08 | 102 |
GO:006219710 | Cervix | CC | cellular response to chemical stress | 76/2311 | 337/18723 | 1.01e-07 | 5.25e-06 | 76 |
GO:003459910 | Cervix | CC | cellular response to oxidative stress | 63/2311 | 288/18723 | 3.58e-06 | 9.50e-05 | 63 |
GO:007099710 | Cervix | CC | neuron death | 70/2311 | 361/18723 | 7.50e-05 | 1.03e-03 | 70 |
GO:190121410 | Cervix | CC | regulation of neuron death | 61/2311 | 319/18723 | 3.11e-04 | 3.31e-03 | 61 |
GO:00170143 | Cervix | CC | protein nitrosylation | 7/2311 | 16/18723 | 1.79e-03 | 1.34e-02 | 7 |
GO:00181193 | Cervix | CC | peptidyl-cysteine S-nitrosylation | 7/2311 | 16/18723 | 1.79e-03 | 1.34e-02 | 7 |
GO:003647310 | Cervix | CC | cell death in response to oxidative stress | 21/2311 | 95/18723 | 5.32e-03 | 3.10e-02 | 21 |
GO:0006979111 | Esophagus | ESCC | response to oxidative stress | 303/8552 | 446/18723 | 7.15e-22 | 1.30e-19 | 303 |
GO:0062197111 | Esophagus | ESCC | cellular response to chemical stress | 234/8552 | 337/18723 | 5.37e-19 | 5.97e-17 | 234 |
GO:0034599111 | Esophagus | ESCC | cellular response to oxidative stress | 197/8552 | 288/18723 | 3.76e-15 | 2.15e-13 | 197 |
GO:0070997111 | Esophagus | ESCC | neuron death | 216/8552 | 361/18723 | 3.49e-08 | 6.45e-07 | 216 |
GO:1901214111 | Esophagus | ESCC | regulation of neuron death | 186/8552 | 319/18723 | 3.35e-06 | 3.73e-05 | 186 |
GO:003647320 | Esophagus | ESCC | cell death in response to oxidative stress | 59/8552 | 95/18723 | 9.12e-04 | 4.65e-03 | 59 |
GO:190121516 | Esophagus | ESCC | negative regulation of neuron death | 115/8552 | 208/18723 | 3.24e-03 | 1.34e-02 | 115 |
GO:190288220 | Esophagus | ESCC | regulation of response to oxidative stress | 58/8552 | 98/18723 | 4.86e-03 | 1.88e-02 | 58 |
GO:190320316 | Esophagus | ESCC | regulation of oxidative stress-induced neuron death | 19/8552 | 27/18723 | 8.35e-03 | 2.95e-02 | 19 |
GO:190040720 | Esophagus | ESCC | regulation of cellular response to oxidative stress | 52/8552 | 89/18723 | 1.04e-02 | 3.56e-02 | 52 |
GO:190320120 | Esophagus | ESCC | regulation of oxidative stress-induced cell death | 44/8552 | 74/18723 | 1.18e-02 | 3.94e-02 | 44 |
GO:00069797 | Liver | NAFLD | response to oxidative stress | 78/1882 | 446/18723 | 7.85e-07 | 4.29e-05 | 78 |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
hsa0414222 | Esophagus | ESCC | Lysosome | 102/4205 | 132/8465 | 5.11e-11 | 7.13e-10 | 3.65e-10 | 102 |
hsa0414232 | Esophagus | ESCC | Lysosome | 102/4205 | 132/8465 | 5.11e-11 | 7.13e-10 | 3.65e-10 | 102 |
hsa041424 | Liver | Cirrhotic | Lysosome | 68/2530 | 132/8465 | 1.34e-07 | 1.97e-06 | 1.21e-06 | 68 |
hsa0414211 | Liver | Cirrhotic | Lysosome | 68/2530 | 132/8465 | 1.34e-07 | 1.97e-06 | 1.21e-06 | 68 |
hsa041422 | Liver | HCC | Lysosome | 100/4020 | 132/8465 | 2.32e-11 | 4.31e-10 | 2.40e-10 | 100 |
hsa041423 | Liver | HCC | Lysosome | 100/4020 | 132/8465 | 2.32e-11 | 4.31e-10 | 2.40e-10 | 100 |
hsa041425 | Oral cavity | OSCC | Lysosome | 87/3704 | 132/8465 | 1.97e-07 | 1.35e-06 | 6.86e-07 | 87 |
hsa0414212 | Oral cavity | OSCC | Lysosome | 87/3704 | 132/8465 | 1.97e-07 | 1.35e-06 | 6.86e-07 | 87 |
hsa0414221 | Oral cavity | LP | Lysosome | 67/2418 | 132/8465 | 5.13e-08 | 7.77e-07 | 5.01e-07 | 67 |
hsa0414231 | Oral cavity | LP | Lysosome | 67/2418 | 132/8465 | 5.13e-08 | 7.77e-07 | 5.01e-07 | 67 |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
NCOA7 | SNV | Missense_Mutation | c.92N>T | p.Ala31Val | p.A31V | Q8NI08 | protein_coding | tolerated_low_confidence(0.3) | benign(0) | TCGA-G4-6588-01 | Colorectum | colon adenocarcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |
NCOA7 | SNV | Missense_Mutation | novel | c.966N>A | p.Phe322Leu | p.F322L | Q8NI08 | protein_coding | deleterious(0.03) | probably_damaging(0.94) | TCGA-AG-A002-01 | Colorectum | rectum adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | SD |
NCOA7 | SNV | Missense_Mutation | novel | c.1784N>A | p.Ser595Tyr | p.S595Y | Q8NI08 | protein_coding | tolerated(0.5) | benign(0.254) | TCGA-AG-A002-01 | Colorectum | rectum adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | SD |
NCOA7 | deletion | Frame_Shift_Del | c.1660delN | p.Gly555GlufsTer2 | p.G555Efs*2 | Q8NI08 | protein_coding | TCGA-AD-5900-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD | |||
NCOA7 | deletion | Frame_Shift_Del | c.1660delN | p.Gly555GlufsTer2 | p.G555Efs*2 | Q8NI08 | protein_coding | TCGA-AY-6197-01 | Colorectum | colon adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | SD | |||
NCOA7 | deletion | Frame_Shift_Del | rs749319230 | c.209delA | p.Lys70ArgfsTer7 | p.K70Rfs*7 | Q8NI08 | protein_coding | TCGA-CM-6171-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | ||
NCOA7 | SNV | Missense_Mutation | novel | c.640N>T | p.Asp214Tyr | p.D214Y | Q8NI08 | protein_coding | deleterious(0) | probably_damaging(0.998) | TCGA-A5-A0G2-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Unknown | Unknown | SD |
NCOA7 | SNV | Missense_Mutation | novel | c.1755N>T | p.Lys585Asn | p.K585N | Q8NI08 | protein_coding | tolerated(0.18) | benign(0.023) | TCGA-A5-A0G2-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Unknown | Unknown | SD |
NCOA7 | SNV | Missense_Mutation | novel | c.623C>T | p.Ser208Leu | p.S208L | Q8NI08 | protein_coding | deleterious(0) | probably_damaging(0.995) | TCGA-AJ-A3EL-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
NCOA7 | SNV | Missense_Mutation | rs777587206 | c.814N>G | p.Met272Val | p.M272V | Q8NI08 | protein_coding | deleterious(0.02) | probably_damaging(0.964) | TCGA-AJ-A3OJ-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Chemotherapy | carboplatin | CR |
Page: 1 2 3 4 5 6 7 8 9 10 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |